Ipower Inc. current report, 21 February 2024

iPower Inc. Form 8-K Summary

Business Context and Reporting Period

iPower Inc. filed a Form 8-K regarding its continued listing on The Nasdaq Capital Market. The reported event occurred on February 21, 2024; the report was signed and dated February 22, 2024. The company’s common stock trades under the symbol IPW.

Financial and Other Key Metrics

This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.

Material Changes Versus the Prior Comparable Period

  • Nasdaq previously notified the company on August 24, 2023 that its common stock had traded below the $1.00 minimum closing bid price required by Nasdaq Listing Rule 5550(a)(2) for 30 consecutive business days.
  • The initial 180-day compliance period was scheduled to expire on February 20, 2024.
  • On February 13, 2024, the company submitted a compliance plan requesting additional time.
  • On February 21, 2024, Nasdaq approved an additional 180-day grace period, extending the compliance deadline to August 19, 2024.

Guidance, Outlook, Risks, Contingencies, and Unusual Items

The company must regain compliance by achieving a closing bid price of at least $1.00 for a minimum of 10 consecutive business days before the August 19, 2024 deadline. The company stated that its compliance plan may include a reverse stock split if deemed necessary.

If compliance is not regained by the deadline, Nasdaq may issue a delisting notification. The company may then appeal the determination to a Nasdaq Hearings Panel. The company stated that there can be no assurance that it will regain compliance or satisfy other Nasdaq listing requirements. Its common stock remains listed and trading on Nasdaq unless further action is taken.

Important Facts for Investors to Verify

  • Whether IPW achieved a closing bid price of at least $1.00 for 10 consecutive business days before August 19, 2024.
  • Whether the company implemented a reverse stock split or another measure to address the bid-price deficiency.
  • Whether Nasdaq issued any subsequent compliance, delisting, or hearing-related notices.
  • Whether the company remains in compliance with all other Nasdaq continued-listing requirements.